BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25190124)

  • 21. Need for a revised staging consensus in medullary thyroid carcinoma.
    Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
    Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of surgical treatment of papillary thyroid carcinoma].
    Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.
    Riemann B; Krämer JA; Schmid KW; Dralle H; Dietlein M; Schicha H; Sauerland C; Frankewitsch T; Schober O;
    Nuklearmedizin; 2010; 49(3):79-84. PubMed ID: 20505894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
    Hughes CJ; Shaha AR; Shah JP; Loree TR
    Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma.
    Zuniga S; Sanabria A
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1087-91. PubMed ID: 19917919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
    Brownlie BJ; Turner J; Abdelaal AS
    N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause-specific mortality in patients with mucoepidermoid carcinoma of the major salivary glands.
    Ali S; Sarhan M; Palmer FL; Whitcher M; Shah JP; Patel SG; Ganly I
    Ann Surg Oncol; 2013 Jul; 20(7):2396-404. PubMed ID: 23397152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
    Fleischmann A; Schobinger S; Schumacher M; Thalmann GN; Studer UE
    Prostate; 2009 Mar; 69(4):352-62. PubMed ID: 19016478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.
    Shaha MA; Wang LY; Migliacci JC; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
    Thyroid; 2017 Mar; 27(3):412-417. PubMed ID: 27855574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.